BioCentury | Jan 22, 2020
Finance

HepaRegeniX aims to bring liver program into clinic with €11M insider round

...Frank Hensel told BioCentury the presence of deep-pocketed investors such as BIVF and Novo afforded HepaRegeniX GmbH...
...clinical development. The company could also choose to license its molecule, he said. Paul Bonanos, Associate Editor HepaRegeniX GmbH Mitogen-activated...
BioCentury | Mar 30, 2017
Emerging Company Profile

Unlocking liver regeneration

...and chronic liver diseases eventually cause liver failure, the only approved treatment is liver transplantation. HepaRegeniX GmbH...
...from Ascenion GmbH , the tech transfer organization for multiple German research institutes. COMPANY PROFILE HepaRegeniX GmbH...
...covering inhibitors of MKK4 for liver regeneration Companies and Institutions Mentioned Ascenion GmbH, Munich, Germany HepaRegeniX GmbH...
BioCentury | Mar 9, 2017
Finance

Pharmas learn their A, B, seeds

...Seeds and Boehringer Ingelheim Venture Fund GmbH led a €9 million series A fund for HepaRegenix GmbH...
...Co. (NYSE:LLY), Indianapolis, Ind. Galecto Biotech AB, Copenhagen, Denmark GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. HepaRegenix GmbH...
Items per page:
1 - 3 of 3
BioCentury | Jan 22, 2020
Finance

HepaRegeniX aims to bring liver program into clinic with €11M insider round

...Frank Hensel told BioCentury the presence of deep-pocketed investors such as BIVF and Novo afforded HepaRegeniX GmbH...
...clinical development. The company could also choose to license its molecule, he said. Paul Bonanos, Associate Editor HepaRegeniX GmbH Mitogen-activated...
BioCentury | Mar 30, 2017
Emerging Company Profile

Unlocking liver regeneration

...and chronic liver diseases eventually cause liver failure, the only approved treatment is liver transplantation. HepaRegeniX GmbH...
...from Ascenion GmbH , the tech transfer organization for multiple German research institutes. COMPANY PROFILE HepaRegeniX GmbH...
...covering inhibitors of MKK4 for liver regeneration Companies and Institutions Mentioned Ascenion GmbH, Munich, Germany HepaRegeniX GmbH...
BioCentury | Mar 9, 2017
Finance

Pharmas learn their A, B, seeds

...Seeds and Boehringer Ingelheim Venture Fund GmbH led a €9 million series A fund for HepaRegenix GmbH...
...Co. (NYSE:LLY), Indianapolis, Ind. Galecto Biotech AB, Copenhagen, Denmark GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. HepaRegenix GmbH...
Items per page:
1 - 3 of 3